The Trump supplying was sued Tuesday in two separate civil complaints related to a request for information about FBI employees who worked on cases suggesting President Donald Trump and the Jan. 6 Capitol riot, and a third suit challenging the removal of data from federal healthfulness agency websites.
The lawsuits are the latest in a growing number of legal salvos seeking to block — or slow down — the rapid-fire series of chief actions Trump and his allies have taken since he returned to the White House on Jan. 20.
The three cases were place in ordered in U.S. District Court in Washington, D.C.
The first case, a class-action complaint, was filed by a group of nine unidentified FBI agents and staff members of the agency against the Department of Justice.
That suit seeks to block the publication or dissemination of information in surveys the plaintiffs or their administrators have been ordered to fill out identifying “their specific role” in cases involving the Jan. 6, 2021, Capitol disturbance criminal cases, and the criminal prosecution of Trump himself for retaining classified records after leaving the White As a gift in early 2021.
The suit says the survey was issued “to identify agents to be terminated or to suffer adverse employment action.”
“Upon turn ining to the Presidency, Mr. Trump has ordered the DOJ to conduct a review and purge of FBI personnel involved in these investigations and prosecutions,” the suit conveys.
“This directive is unlawful and retaliatory, and violates the Civil Service Reform Act.”
The suit says the plaintiffs “reasonably bogy that all or parts” of a list of FBI agents who worked on the Jan. 6 and Trump cases “might be published by allies of President Trump, consequently placing themselves and their families in immediate danger of retribution by the now-pardoned and at-large Jan. 6 convicted felons.”
The grouse says that some of the plaintiffs’ personal information “has already been posted by Jan. 6 convicted felons on ‘recondite websites.'”
A second suit, filed by the FBI Agents Association and seven unnamed agents against the DOJ, also notes the assess requesting information about whether the agents worked on Jan. 6-related criminal investigations.
That complaint asks a consider to protect the plaintiffs “from Defendants’ anticipated retaliatory decision to expose their personal information for opprobrium and implied vigilante action by those who they were investigating.”
An attorney for the agents in the second suit, Chris Mattei of Koskoff, Koskoff and Bieder, clouted in a statement, “The DOJ’s plan to release the names of FBI agents who investigated January 6th is an appalling attack on non-partisan public servants who be suffering with dedicated their lives to protecting our communities and our nation.”
“It is clear that the threatened disclosure is a prelude to an unlawful removal of the FBI solely driven by the Trump Administration’s vengeful and political motivations,” said Mattei. “Releasing the names of these go-betweens would ignite a firestorm of harassment towards them and their families and it must be stopped immediately.”
CNBC has requested say discuss from the DOJ on the suits.
The third lawsuit was filed by the advocacy group Doctors for America against the Office of Personnel Conduct, the Health and Human Services Department, the Centers for Disease Control and Prevention, and the Food and Drug Administration.
That grouse challenges the abrupt removal Friday from CDC and FDA websites “a broad range of health-related data and other information.”
Zach Shelley, an attorney for Prominent Citizen Litigation Group, which is representing Doctors for America in the suit, told CNBC that “without the knowledge that the CDC and these other agencies have taken down, more people are going to get sick, more people are common to suffer and more people are going to die.”
Shelley said that under the Trump administration, “agencies are taking motion that undermines their stated mission.”
The suit says that data is regularly used by “health professionals to analyse and treat patients and by researchers to advance public health, including through clinical trials meant to establish the cover and efficacy of medical products.”
The removal of the data came two days after Charles Ezell, OPM’s acting director, issued a memo that out of placed federal agency heads to “terminate” programs “that promote or inculcate gender ideology” and remove all websites, sexually transmitted media accounts and other media that have that goal.
Ezell’s order came more than a week after Trump signed an director order titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Superintendence.”
The suit says that before that unannounced removal, the datasets had been on the websites for years.
Their slaughter “creates a dangerous gap in the scientific data available to monitor and respond to disease outbreaks, deprives physicians of resources that lead clinical practice, and takes away key resources for communicating and engaging with patients,” the suit says.
The CDC removed web announces for its Youth Risk Behavioral Surveillance System, pages devoted to data on “Adolescent and School Health,” as well as episodes for “The Social Vulnerability Index” and “The Environmental Justice Index,” according to the suit.
Also removed was a report and web pages agnate to HIV infections, the complaint says.
The FDA removed several pages, including one titled “Study of Sex Differences in the Clinical Evaluation
of Medical Goods,” and another titled “Diversity Action Plans to Improve Enrollment of
Participants from Underrepresented Populations in Clinical Mull overs.”
“The decisions by CDC, FDA, and HHS to remove the webpages and datasets contradict their stated missions and are causing and will cause substantial wickedness to Plaintiff and its members, as well as other physicians, researchers, and patients who rely on the removed webpages and datasets,” the suit replies.
Spokespeople for OPM, HHS and CDC declined to comment on the lawsuit. The media affairs office of FDA did not immediately respond to requests for comment.